Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | +8.11% | -0.98% | +72.55% |
May. 06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
Apr. 10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.55% | 12.5M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Chemomab Therapeutics Ltd. Names Donald R. Marvin, Executive Vice President and Chief Operating Officer